1,203
Participants
Start Date
February 14, 2017
Primary Completion Date
October 11, 2018
Study Completion Date
March 31, 2021
BioFreedom™ Drug Coated Coronary Stent System
a non-surgical procedure that uses a catheter to place a stent to open up coronary arteries that have been narrowed by atherosclerosis
Antiplatelet Drug
Dual antiplatelet therapy for one month followed by single antiplatelet therapy indefinitely. Aspirin and clopidogrel (or other P2Y12 inhibitor) will be used and dosing is according to standard institutional practice
Rigshospitalet Copenhagen University Hospital, Copenhagen
Weill Cornell Medical College-New York Presbyterian, New York
Columbia University Medical Center/New York Presbyterian Hospital, New York
Clinique Axium, Aix-en-Provence
University of Buffalo, Buffalo
Penn State - Milton S. Hershey Medical Center, Hershey
Pinnacle Health Cardiovascular Institute, Wormleysburg
Penn Presbyterian Medical Center, Philadelphia
Berks Cardiologists, Ltd., Reading
MedStar Washington Hospital Center, Washington D.C.
Grande Ospedale Metropolitano Niguarda, Milan
Clinique de Fontaine, Fontaine-lès-Dijon
Carilion Clinic, Roanoke
LeBauer Cardiovascular Research Foundation, Greensboro
NC Heart and Vascular Research, Raleigh
Novant Health Heart and Vascular Institute, Charlotte
AnMed Health, Anderson
North Georgia Heart Foundation, Gainesville
University of Florida Jacksonville, Jacksonville
Tallahassee Research Institute, Inc., Tallahassee
Velella Research, Sarasota
Heart Center Research, LLC, Huntsville
Chattanooga Heart Institute, Chattanooga
Tennova Healthcare-Turkey Creek Medical Center, Knoxville
Groupe Hospitalier Mutualiste de Grenoble, Grenoble
Jewish and St. Mary's Hospital, Louisville
Genesis Healthcare System, Zanesville
St. Vincent Heart Center, Indianapolis
William Beaumont Hospital, Royal Oak
MidMichigan Medical Center Midland, Midland
McLaren Bay Region, Bay City
Black Hills Cardiovascular Research, Rapid City
Jesse Brown VA Medical Center, Chicago
Service de Cardiologie Interventionnelle - Pôle Santé République, Clermont-Ferrand
Saint Luke's Hospital of Kansas City, Kansas City
Missouri Cardiovascular Specialists, LLP, Columbia
Tri-Lakes Research, Hot Springs
Clinique Saint Hilaire, Rouen
Providence Health Center, Waco
Houston Methodist Hospital, Houston
St. Luke's Idaho Cardiology Associates, Boise
Hôpital Privé Jacques Cartier ICPS, Massy
Hôpital Privé Claude Galien, Quincy-sous-Sénart
Scripps Health, La Jolla
University of California San Diego, La Jolla
Santa Barbara Cottage Hospital, Santa Barbara
Lahey Clinic, Burlington
Rhode Island Hospital, Providence
Mazankowski Alberta Heart Institute, Edmonton
Fraser Clinical Trials Inc., New Westminster
St. Paul's Hospital, Vancouver
Victoria Heart Institute Foundation, Victoria
Hamilton Health Sciences, Hamilton
The University of Ottawa Heart Institute, Ottawa
Montreal Heart Institute, Montreal
Hôpital Maisonneuve-Rosemont, Montreal
Centre Hospitalier de l'université de Montréal, Montreal
Institut universitaire de cardiologie et de pneumologie de Québec, Québec
CIUSSS de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke
CHU Toulouse Rangeuil, Toulouse
Segeberger Kliniken GmbH, Bad Segeberg
Royal Bournemouth Hospital, Dorset Heart Centre, Bournemouth
Herzzentrum Leipzig GmbH, Leipzig
Azienda Ospedaliera San Camillo Forlanini, Rome
Craigavon Cardiac Centre, Craigavon
Golden Jubilee National Hospital, Glasgow
Biosensors Europe SA
INDUSTRY